1 |
Cao L, Jiang Y, Zhang X, Gu Z, Liu Z, Ding L. The Prognosis of Pineal Parenchymal Tumors: Development and Validation of a Nomogram Based on Surveillance, Epidemiology and End Results. World Neurosurg 2023:S1878-8750(23)00237-1. [PMID: 36841539 DOI: 10.1016/j.wneu.2023.02.084] [Reference Citation Analysis]
|
2 |
Suzuki T, Shirahata M, Adachi JI, Mishima K, Nishikawa R. Clinical significance and pitfalls of human chorionic gonadotropin-related tumor markers for intracranial germinomas. Childs Nerv Syst 2023. [PMID: 36745216 DOI: 10.1007/s00381-023-05856-w] [Reference Citation Analysis]
|
3 |
Liu C, Carmicheal J, Baine MJ, Zhang C. Radiation therapy for pineal parenchymal tumor of intermediate differentiation: A case series and literature review. J Cent Nerv Syst Dis 2023;15:11795735231160036. [PMID: 36949932 DOI: 10.1177/11795735231160036] [Reference Citation Analysis]
|
4 |
Webb M, Johnson DR, Mahajan A, Brown P, Neth B, Kizilbash SH, Sener U. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis. J Neurooncol 2022. [DOI: 10.1007/s11060-022-04174-6] [Reference Citation Analysis]
|
5 |
Paun L, Lavé A, Patet G, Bartoli A. Supratentorial Pediatric Midline Tumors and Tumor-like Lesions: Clinical Spectrum, Natural History and Treatment Options. Children 2022;9:534. [DOI: 10.3390/children9040534] [Reference Citation Analysis]
|
6 |
Mahajan A, Shih H, Penas-prado M, Ligon K, Aldape K, Hu LS, Loughan AR, Basso MR, Leeper HE, Nahed BV, Stott SL, Geyer S, Giannini C, Galanis E. The Alliance AMBUSH Trial: Rationale and Design. Cancers 2022;14:414. [DOI: 10.3390/cancers14020414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|